Blood Tests for Metabolic Syndrome
The 5 diagnostic criteria with exact Australian cut-offs, which tests are Medicare bulk-billed, and a practical plan to reverse the cluster — in plain English.
Free to use · No credit card · Works with any Australian lab
The Quick Answer
Metabolic syndrome is not a single disease — it is a cluster of five metabolic abnormalities that tend to occur together, driven by underlying insulin resistance and central obesity. It is diagnosed when a person meets 3 or more of the following 5 criteria:
Central obesity (large waist circumference)
Raised triglycerides (at or above 1.7 mmol/L)
Low HDL cholesterol
Raised blood pressure (at or above 130/85 mmHg)
Raised fasting glucose (at or above 5.6 mmol/L)
The significance of metabolic syndrome is not any single criterion in isolation — it is the clustering. Three criteria together raises the 10-year cardiovascular risk 2-3 times compared to having none. Five criteria together pushes that risk even higher, particularly for type 2 diabetes.
The 5 Criteria — Exact Australian Cut-offs
Using the internationally harmonised IDF/AHA/NHLBI criteria adopted in Australian guidelines. Three or more criteria = metabolic syndrome. People already on medication for any criterion (antihypertensives, triglyceride-lowering medication, glucose-lowering medication) automatically meet that criterion regardless of their current result.
Central obesity (waist circumference)
Measured at the midpoint between the lowest rib and the iliac crest, at the end of a normal exhalation. Ethnicity-specific thresholds apply because South Asian and East Asian populations accumulate dangerous visceral fat at lower waist measurements than Europid populations.
Raised triglycerides
Fasting sample required for accurate triglyceride measurement. A non-fasting value above 2.0 mmol/L is also considered elevated. People already on fibrates or omega-3 therapy for triglycerides automatically meet this criterion.
Low HDL cholesterol
HDL is the so-called "good" cholesterol that removes lipids from arteries. Low HDL is closely coupled with high triglycerides in insulin-resistant dyslipidaemia. People on HDL-raising medication automatically meet this criterion.
Raised blood pressure
Systolic at or above 130 OR diastolic at or above 85 meets the criterion. People already on antihypertensive medication automatically meet this criterion regardless of their current blood pressure reading.
Raised fasting glucose
Fasting sample required (8-12 hours, water only). This threshold is lower than the prediabetes cut-off in some guidelines because metabolic syndrome criteria are designed to identify people before diabetes is established. People on glucose-lowering medication automatically meet this criterion.
Beyond the 5 Criteria — Additional Useful Markers
The 5 criteria define metabolic syndrome, but these additional markers give a deeper picture of severity, underlying insulin resistance, and cardiovascular risk.
Fasting insulin and HOMA-IR
Reveals the underlying insulin resistance that drives metabolic syndrome, often before all 5 criteria are met. Tracks improvement with treatment.
Target: HOMA-IR below 1.5; insulin below 7 mIU/LALT (liver enzyme)
Elevated in metabolic-associated steatotic liver disease (MASLD/NAFLD), which is present in 70-90% of people with metabolic syndrome.
Target: Below 25 U/L (women), below 33 U/L (men)GGT (gamma-glutamyl transferase)
Sensitive marker of liver fat and oxidative stress. Often elevated in metabolic syndrome even before ALT rises significantly.
Target: Below 30 U/LUric acid
Elevated in metabolic syndrome via reduced renal excretion caused by hyperinsulinaemia. Predicts gout and is an independent cardiovascular risk factor.
Target: Below 360 umol/LHbA1c
Complements fasting glucose. Useful for staging glucose dysregulation within the metabolic syndrome spectrum (normal, prediabetes, diabetes range).
Target: Below 5.7% (39 mmol/mol)ApoB or non-HDL cholesterol
Standard LDL-C underestimates cardiovascular risk in metabolic syndrome due to the shift to small dense LDL particles. ApoB or non-HDL give a truer picture of atherogenic particle burden.
Target: ApoB below 0.8 g/L; non-HDL below 2.6 mmol/LWhy Metabolic Syndrome Matters — The Health Consequences
The risks below apply when 3 or more metabolic syndrome criteria are met. Meeting more criteria or having more extreme values increases risk further.
Type 2 diabetes
Insulin resistance plus progressive beta-cell failure from chronic hyperinsulinaemia
Cardiovascular disease
Atherogenic dyslipidaemia, hypertension, hyperglycaemia, and procoagulant state act simultaneously
Stroke
Hypertension plus thrombogenic tendency plus carotid atherosclerosis
MASLD/NAFLD (fatty liver)
Insulin-driven hepatic fat accumulation; up to 90% of people with metabolic syndrome have fatty liver
PCOS
Insulin resistance drives ovarian androgen excess; metabolic syndrome and PCOS frequently co-occur
Sleep apnoea
Visceral adiposity and upper airway fat deposition; sleep apnoea worsens insulin resistance in a vicious cycle
Certain cancers
Hyperinsulinaemia is a growth signal for some cancers including colorectal, endometrial, and pancreatic
How to Reverse Metabolic Syndrome
Metabolic syndrome is one of the most treatment-responsive conditions in medicine when the underlying cause — insulin resistance plus visceral fat — is addressed directly. A 5-10% reduction in body weight resolves metabolic syndrome criteria in roughly half of those affected.
Reduce refined carbohydrates and added sugar
The primary dietary driver of insulin resistance. Replacing refined starches (white bread, rice, pasta, pastries), sugary drinks, and confectionery with vegetables, legumes, whole grains, nuts, and protein directly lowers triglycerides and fasting insulin within 4-8 weeks.
Achieve a calorie deficit to drive weight loss
Even modest weight loss (3-5 kg) shifts multiple criteria simultaneously. Triglycerides and blood pressure typically respond fastest, often within the first 4-8 weeks of consistent calorie reduction. A dietitian referral is extremely cost-effective for this condition.
Combine aerobic and resistance exercise
Aerobic exercise (brisk walking, cycling, swimming - aim for 150 minutes per week) lowers blood pressure and improves insulin sensitivity. Resistance training (2-3 sessions per week) builds metabolically active muscle mass that improves glucose disposal independently of weight loss.
Prioritise sleep quality
Poor sleep (below 6-7 hours, or fragmented by sleep apnoea) raises fasting glucose, insulin, and blood pressure within days. Screening for obstructive sleep apnoea is particularly important in people with central obesity and metabolic syndrome - treating it often improves multiple criteria.
Manage stress
Chronic stress raises cortisol, which promotes visceral fat deposition, raises blood pressure, and worsens insulin resistance. Stress reduction strategies (exercise, mindfulness, social connection, reducing work overload) have measurable metabolic effects.
Medication when lifestyle is insufficient
Statins (for dyslipidaemia and cardiovascular risk), antihypertensives (for blood pressure), metformin (for glucose), and GLP-1 receptor agonists or SGLT-2 inhibitors (for weight, glucose, and cardiovascular risk) are PBS-subsidised for eligible Australians with appropriate indications.
Your Step-by-Step Action Plan
Book a fasting blood test and clinic review with your GP
Ask for: fasting glucose, full lipid panel (triglycerides + HDL + LDL + total cholesterol), and liver function tests (ALT + GGT). These are all Medicare bulk-billed with a valid referral. Also add fasting insulin and uric acid for a small private-pay cost (~$35-$60 extra). Have your blood pressure and waist circumference measured at the appointment.
Count how many of the 5 criteria you meet
Tally waist circumference, triglycerides, HDL, blood pressure, and fasting glucose against the thresholds above. Use ethnicity-appropriate waist cut-offs. Meeting 3 or more criteria = metabolic syndrome. Meeting 2 criteria = significant risk, act now before a third criterion appears.
Understand your total cardiovascular risk
Metabolic syndrome significantly increases absolute cardiovascular risk. Your GP can calculate your 5- or 10-year cardiovascular risk using the Australian cardiovascular risk calculator, which incorporates age, sex, blood pressure, cholesterol, and diabetes status. Use this number to frame the urgency of lifestyle change.
Set targets for each criterion
Each criterion has a target: waist below 90 cm (men) / 80 cm (women), triglycerides below 1.7 mmol/L, HDL above 1.0/1.3 mmol/L, blood pressure below 130/80 mmHg, fasting glucose below 5.6 mmol/L. Weight loss of 5-10% typically moves multiple criteria simultaneously.
Retest at 12-16 weeks
After initiating lifestyle changes (or medication), retest all blood markers and have blood pressure and waist measured again. Even modest improvements across multiple criteria meaningfully reduce cardiovascular risk. The cluster responds faster to intervention than any individual chronic disease marker.
Track all 5 criteria over time
Upload your serial blood test results to SmarterBlood to see every metabolic syndrome marker plotted on a timeline. Watching triglycerides fall, HDL rise, and fasting glucose normalise over months is motivating and helps your GP see which criteria still need attention.
Australian Healthcare Resources for Metabolic Syndrome
Several Medicare-subsidised programs are available for Australians with metabolic syndrome or high cardiovascular risk:
Chronic Disease Management (CDM) plan (GP Management Plan)
If you have metabolic syndrome or 2+ chronic conditions, your GP can create a CDM plan that provides Medicare rebates for up to 5 allied health visits per year, including dietitian, exercise physiologist, and diabetes educator consultations. This is one of the most valuable and underused programs for metabolic syndrome management.
Diabetes Prevention Program (Life! Program in Victoria)
The federal government and several state health departments fund lifestyle modification programs for people at high risk of type 2 diabetes, which includes most people with metabolic syndrome. The Life! Program in Victoria is a well-researched group-based lifestyle intervention. Ask your GP about equivalent programs in your state.
Heart Health Check (MBS item 699)
All Australians aged 45-79 (30-79 for Aboriginal and Torres Strait Islander people) are eligible for a free Heart Health Check with their GP. This includes cardiovascular risk calculation, lipid panel, blood pressure, and discussion of risk reduction. Metabolic syndrome is directly relevant to this check.
National Diabetes Services Scheme (NDSS)
Available to Australians diagnosed with diabetes or prediabetes. Provides subsidised diabetes-related products and access to education and support services. Relevant for people with metabolic syndrome who progress to prediabetes or type 2 diabetes.
Blood Tests for Metabolic Syndrome - Frequently Asked Questions
What is metabolic syndrome?
Metabolic syndrome is a cluster of five interconnected metabolic abnormalities that, when present together, dramatically raise the risk of type 2 diabetes, heart disease, stroke, and fatty liver disease. It is diagnosed when a person has 3 or more of the following 5 criteria: central obesity (large waist circumference), raised triglycerides, low HDL cholesterol, raised blood pressure, and raised fasting glucose. Each criterion alone carries some risk; together they are synergistic, meaning the combined risk is greater than the sum of the parts.
What are the exact cut-offs for metabolic syndrome in Australia?
Using the IDF/AHA/NHLBI harmonised criteria (used in Australian guidelines): central obesity - waist above 94 cm (men) or 80 cm (women) for Europid/Caucasian; for East Asian, South Asian, Aboriginal and Torres Strait Islander people the cut-offs are 90 cm (men) and 80 cm (women). Raised triglycerides: at or above 1.7 mmol/L (or on triglyceride-lowering medication). Low HDL: below 1.0 mmol/L (men) or below 1.3 mmol/L (women) (or on HDL-raising medication). Raised blood pressure: at or above 130/85 mmHg (or on antihypertensive medication). Raised fasting glucose: at or above 5.6 mmol/L (or on glucose-lowering medication).
Which metabolic syndrome tests are bulk-billed in Australia?
With a valid GP referral, the blood test components of metabolic syndrome are almost entirely Medicare bulk-billed: fasting glucose (MBS 66503), triglycerides and HDL as part of the lipid panel (MBS 66500), and liver function tests (often requested alongside). Blood pressure is measured in the clinic at no cost. Waist circumference is measured in the clinic. The only add-on markers (fasting insulin, uric acid) that provide additional context are private-pay (~$20-$40 total). This makes metabolic syndrome screening one of the most cost-effective health checks available in Australia.
How common is metabolic syndrome in Australia?
Metabolic syndrome affects approximately 25-35% of Australian adults, with prevalence rising sharply with age. By age 60-69, roughly 40-50% of Australians meet the criteria. It is more common in people with type 2 diabetes, PCOS, non-alcoholic fatty liver disease, sleep apnoea, and those of South Asian, Pacific Islander, or Aboriginal and Torres Strait Islander background. The condition is significantly underdiagnosed because no single criterion triggers investigation - it requires looking at all five together.
Can metabolic syndrome be reversed?
Yes - metabolic syndrome is largely reversible with sustained lifestyle change, particularly weight loss. Losing 7-10% of body weight resolves metabolic syndrome criteria in roughly 50-60% of people. The most powerful interventions are: reducing refined carbohydrates and added sugars, achieving a caloric deficit to drive weight loss, increasing physical activity (aerobic plus resistance training), improving sleep, and managing stress. For people who cannot achieve adequate improvement with lifestyle alone, medications targeting individual criteria (statins, antihypertensives, metformin, GLP-1 agonists) are added.
Is metabolic syndrome the same as insulin resistance?
Insulin resistance is the underlying mechanism that drives most cases of metabolic syndrome. Virtually all people with metabolic syndrome have insulin resistance, but not everyone with insulin resistance has metabolic syndrome (they may only meet 1 or 2 criteria). Think of insulin resistance as the root cause and metabolic syndrome as the downstream cluster of measurable consequences. Measuring fasting insulin or HOMA-IR can reveal insulin resistance even before all 5 metabolic syndrome criteria are met.
Why does waist circumference matter more than BMI for metabolic syndrome?
Waist circumference specifically measures central (abdominal) adiposity, which reflects visceral fat - the fat stored around internal organs including the liver, pancreas, and intestines. Visceral fat is metabolically active and directly drives insulin resistance, inflammation, and dyslipidaemia. BMI does not distinguish between visceral fat and subcutaneous fat (under the skin), or between fat and muscle mass. Two people with the same BMI can have very different metabolic risk depending on where their fat is distributed. A lean-looking person can have metabolic syndrome if visceral fat is high, a phenomenon called TOFI (Thin Outside, Fat Inside).
Related Reading
Track Your Metabolic Syndrome Criteria Over Time
Upload your pathology PDF and SmarterBlood's AI explains every metabolic marker — triglycerides, HDL, fasting glucose, ALT, and uric acid — in plain English and plots them on a timeline so you can see the cluster resolving as your lifestyle changes take effect.
This page provides general educational information about metabolic syndrome and its associated blood markers. Diagnostic criteria and reference ranges are based on the internationally harmonised IDF/AHA/NHLBI definition and Australian guidelines as of 2025. They may be updated as evidence evolves. This content is not a substitute for professional medical advice — diagnosis of metabolic syndrome requires a clinical assessment by your GP. SmarterBlood does not provide medical care.